| Literature DB >> 23589162 |
K Akesson1, D Marsh, P J Mitchell, A R McLellan, J Stenmark, D D Pierroz, C Kyer, C Cooper.
Abstract
UNLABELLED: The International Osteoporosis Foundation (IOF) Capture the Fracture Campaign aims to support implementation of Fracture Liaison Services (FLS) throughout the world.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23589162 PMCID: PMC3706734 DOI: 10.1007/s00198-013-2348-z
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Fig. 1The fragility fracture cycle (reproduced with permission of the Department of Health in England [56])
National audits of secondary fracture prevention
| Country | No. of fracture patients | Study population | Fracture risk assessment done or risk factors identified (%) | Treated for osteoporosis (%) | Reference |
|---|---|---|---|---|---|
| Australia | 1,829 | Minimal-trauma fracture presentations to Emergency Departments | – < 13 % had risk factors identified | –12 % received calcium | Teede et al. [ |
| –10 % ‘appropriately investigated’ | –12 % received vitamin D | ||||
| –8 % received a bisphosphonate | |||||
| Canada | 441 | Men participating in the Canadian Multicentre Osteoporosis Study (CaMos) with a prevalent clinical fracture at baseline | –At baseline, 2.3 % reported a diagnosis of osteoporosis | –At baseline, <1 % were taking a bisphosphonate | Papaioannou et al. [ |
| –At year 5, 10.3 % (39/379) with a clinical fragility fracture (incident or prevalent) reported a diagnosis of osteoporosis | –At year 5, the treatment rate for any fragility fracture was 10 % (36/379) | ||||
| Germany | 1,201 | Patients admitted to hospital with an isolated distal radius fracture | 62 % of women and 50 % of men had evidence of osteoporosis | 7 % were prescribed osteoporosis-specific medication | Smektala et al. [ |
| Italy | 2,191 | Ambulatory patients with a previous osteoporotic hip fracture attending orthopaedic clinics | No data | –< 20 % of patients had taken an antiresorptive drug before their hip fracture | Carnevale et al. [ |
| –< 50 % took any kind of treatment for osteoporosis 1.4 years after initial interview | |||||
| Japan | 2,328 | Females suffering their first hip fracture | BMD was measured before or during hospitalisation for 16 % of patients | –19 % of patients received osteoporosis treatment in the year following fracture | Hagino et al. [ |
| –36 % of patients receiving osteoporosis treatment during hospitalisation continued at 1 year | |||||
| Korea | 151,065 | Nationwide cohort of females with hip, spine and wrist fractures | BMD was measured for 23 % with hip fracture, 29 % with spine fracture and 9 % with wrist fracture | ≥1 approved osteoporosis treatment was received by 22 % with hip fracture, 30 % with spine fracture and 8 % with wrist fracture | Gong et al. [ |
| Netherlands | 1,654 | Patients hospitalised for a fracture of the hip, spine, wrist or other fractures | For a sample of 208 out of 1,654 cases, GP case records were available. Of these patients, 5 % had a diagnosis of osteoporosis in the GP records | 15 % of patients received osteoporosis treatment within 1 year after discharge from hospital | Panneman et al. [ |
| Switzerland | 3,667 | Patients presenting with a fragility fracture to hospital emergency wards | BMD was measured for 31 % of patients | 24 % of women and 14 % of men were treated with a bone active drug, generally a bisphosphonate with or without calcium and/or vitamin D | Suhm et al. [ |
| UK | 9,567 | Patients who presented with a hip or non-hip fragility fracture | 32 % of non-hip fracture and 67 % of hip fracture patients had a clinical assessment for osteoporosis and/or fracture risk | 33 % of non-hip fracture and 60 % of hip fracture patients received appropriate management for bone health | Royal College of Physicians [ |
| USA | 51,346 | Patients hospitalised for osteoporotic hip fracture | No data | 7 % received an anti-resorptive or bone-forming medication | Jennings et al. [ |
Fig. 2Defining the scope of an FLS and expansion of fracture population assessed [1] n.b. The ultimate goal of an FLS is to capture 100 % of fragility fracture sufferers. This figure recognises that development of FLS may be incremental
Fig. 3The operational structure of a hospital-based Fracture Liaison Service [73] Asterisk (*) older patients, where appropriate, are identified and referred for falls assessment
| The standards are weighted: | The scores within each standard are: |
| Essential = weight of 1 | Level 1 = 1 |
| Medium = weight of 2 | Level 2 = 2 |
| Aspirational = weight of 3 | Level 3 = 3 |
| Standard | Weight | Level 1 | Level 2 | Level 3 | Achievement Level ENTER Level1/Level2/Level3 SCORE HERE | Standard Total (weight × level) | ||
| 1 | Patient Identification | 1 | x | 1 | 2 | 3 | 0 | |
| 2 | Patient Evaluation | 1 | x | 1 | 2 | 3 | 0 | |
| 3 | Post-fracture Assessment Timing | 2 | x | 1 | 2 | 3 | 0 | |
| 4 | Vertebral Fracture | 3 | x | 1 | 2 | 3 | 0 | |
| 5 | Assessment Guidelines | 3 | x | 1 | 2 | 3 | 0 | |
| 6 | Secondary Causes of Osteoporosis | 3 | x | 1 | 2 | 3 | 0 | |
| 7 | Falls Prevention Services | 1 | x | 1 | 2 | 3 | 0 | |
| 8 | Multifaceted health and lifestyle risk-factor Assessment | 3 | x | 1 | 2 | 3 | 0 | |
| 9 | Medication Initiation | 1 | x | 1 | 2 | 3 | 0 | |
| 10 | Medication Review | 2 | x | 1 | 2 | 3 | 0 | |
| 11 | Communication Strategy | 2 | x | 1 | 2 | 3 | 0 | |
| 12 | Long-term Management | 2 | x | 1 | 2 | 3 | 0 | |
| 13 | Database | 1 | x | 1 | 2 | 3 | 0 | |
| TOTAL Achievement Level | 0 | |||||||